Abstract: Cancer survivors are faced with several survivorship issues. In addition, young women may have to face the challenges brought on by premature menopause. The issue of Hormone Replacement Therapy (HRT) in these young ladies has always been a matter of debate. This article reviews the current recommendations for the use of HRT in various cancers. The newer hormonal replacement therapies have also been discussed.
Cite this paper
Lokanatha, D. , Babu, K. G. and Bhat, G. R. (2015). Role of Hormone Replacement Therapy in Young Women Suffering from Menopausal Symptoms of Cancer —A Concise Review. Open Access Library Journal, 2, e2069. doi: http://dx.doi.org/10.4236/oalib.1102069.
King, J., Wynne, C.H., Assersohn, L. and Jones, A. (2011) Hormone Replacement Therapy and Women with Premature
Menopause—A Cancer Survivorship Issue. European
Journal of Cancer, 47, 1623-1632. http://dx.doi.org/10.1016/j.ejca.2011.04.007
Cusack, L.,
Brennan, M., Baber, R. and
Boyle, F. (2013) Menopausal
Symptoms in Breast Cancer: Management Update. British Journal of General Practice, 63, 51-52. http://dx.doi.org/10.3399/bjgp13X660977
Finck, G.,
Barton, D.L.,
Loprinzi, C.L., et al. (1998) Definitions of Hot Flashes in Breast Cancer Survivors. Journal of Pain and Symptom Management, 16, 327-333. http://dx.doi.org/10.1016/S0885-3924(98)00090-6
Kronenberg, F.
(1994) Hot
Flashes: Phenomenology, Quality of Life, and Search for Treatment Options. Experimental Gerontology, 29,
319-336. http://dx.doi.org/10.1016/0531-5565(94)90012-4
Ganz, P.A.,
Greendale, G.A.,
Petersen, L., et al. (2003) Breast Cancer in Younger Women: Reproductive
and Late Health Effects of Treatment. Journal of Clinical Oncology, 21, 4184-4193. http://dx.doi.org/10.1200/JCO.2003.04.196
Hickey, M.,
Saunders, C.M.
and Stuckey, B.G.A. (2005) Management
of Menopausal Symptoms in Patients with Breast Cancer: An Evidence-Based
Approach. The Lancet Oncology, 6, 687-695. http://dx.doi.org/10.1016/S1470-2045(05)70316-8
Perrone, A.M.,
Pozzati, F.,
Santini, D.,
Rossi, M.,
Procaccini, M.,
Casalini, L., et al. (2014) Gynecological Malignancies and Hormonal Therapies: Clinical Management
and Recommendations. World Journal of Obstetrics and Gynecology, 3, 162-170.
Casper, R.F. (1996) Regulation of Estrogen/Progestogen Receptors in the
Endometrium. International Journal of Fertility and
Menopausal Studies, 41, 16-21.
Murthy, V.
and Chamberlain, R.S. (2012) Menopausal
Symptoms in Young Survivors of Breast Cancer—A Growing Problem without
an Ideal Solution. Cancer Control, 19, 317-329.
Minton, S.E. and Munster, P.N. (2002) Chemotherapy-Induced Amenorrhea and Fertility
in Women Undergoing Adjuvant Treatment for Breast Cancer. Cancer Control, 9, 466-472.
Anderson, R.A., Themmen, A.P., Al-Qahtani, A., Groome, N.P. and Cameron, D.A. (2006) The Effects of Chemotherapy and Long-Term Gonadotrophin
Suppression on the Ovarian Reserve in Premenopausal Women with Breast Cancer. Health Human Reproduction, 21, 2583-2592. http://dx.doi.org/10.1093/humrep/del201
Tominaga, T., Morimoto, T. and Ohasi, Y., for the Japan Letrozole Study Group (2000) A Pivotal Double-Blind Trial in Japan of an Aromatase Inhibitor
Letrozole (Third Generation) vs. Its Predecessor Fadrozole Hydrochloride (Second Generation). Annals of Oncology, 11, 25.
Tham, Y.L.,
Sexton, K.,
Weiss, H.,
Elledge, R.,
Friedman, L.C.
and Kramer, R. (2007) The
Rates of Chemotherapy-Induced
Amenorrhea in Patients Treated with Adjuvant Doxorubicin and Cyclophosphamide
Followed by Ataxane. American Journal of
Clinical Oncology, 30, 126-132. http://dx.doi.org/10.1097/01.coc.0000251398.57630.4f
Lutchman, S.K., Muttukrishna, S.,
Stein, R.C.,
McGarrigle, H.H.,
Patel, A.,
Parikh, B., et al. (2007) Predictors of Ovarian Reserve in Young Women with Breast
Cancer. British Journal of Cancer, 96, 1808-1816. http://dx.doi.org/10.1038/sj.bjc.6603814
Oktay, K.,
Oktem, O.,
Reh, A.
and Vahdat, L. (2006) Measuring
the Impact of Chemotherapy
on Fertility in Women with Breast Cancer. Journal
of Clinical Oncology, 24, 4044-4046. http://dx.doi.org/10.1200/JCO.2006.06.9823
Thygesen, K.H.,
Schjodt, I. and Jarden, M. (2012) The
Impact of Hematopoietic Stem Cell Transplantation on Sexuality: A Systematic
Review of the Literature. Bone Marrow
Transplantation, 47, 716-724. http://dx.doi.org/10.1038/bmt.2011.169
Blumenfeld, Z. (2002) Preservation
of Fertility and Ovarian Function and Minimalization of Chemotherapy Associated Gonadotoxicity and
Premature Ovarian Failure: The Role of Inhibin-A and -B as
Markers. Molecular and Cellular Endocrinology, 187, 93-105. http://dx.doi.org/10.1016/S0303-7207(01)00712-2
Pagani, O.
and Goldhirsch, A. (2006) Breast
Cancer in Young Women: Climbing for Progress in Care and Knowledge. Women’s Health, 2, 717-732. http://dx.doi.org/10.2217/17455057.2.5.717
Holmberg, L. and Anderson, H. (2004) HABITS Steering and Data Monitoring Committees.
HABITS (Hormonal Replacement Therapy after Breast Cancer—Is It Safe?), a
Randomized Comparison: Trial Stopped. Lancet, 363, 453-455. http://dx.doi.org/10.1016/S0140-6736(04)15493-7
Rossouw, J.E., Anderson, G.L., Prentice, R.L., et al. (2002)
Risks and Benefits of Estrogenplus Progestin in Healthy Postmenopausal Women:
Principal Results from the Women’s Health Initiative Randomized Controlled
Trial. JAMA, 288, 321-333. http://dx.doi.org/10.1001/jama.288.3.321
Chlebowski, R.T., Schwartz, A.G., Wakelee, H., et al. (2009)
Oestrogen plus Progestinand Lung Cancer in Postmenopausal Women (Women’s Health
Initiative Trial): Apost-Hoc Analysis of a Randomised Controlled Trial. Lancet, 374, 1243-1251. http://dx.doi.org/10.1016/S0140-6736(09)61526-9
Kenemans, P.,
Bundred, N.J.,
Foidart, J.M.,
Kubista, E.,
von Schoultz, B.,
Sismondi, P., et al. (2009) Safety and Efficacy of Tibolone in Breast-Cancer
Patients with Vasomotor Symptoms: A Double-Blind, Randomized, Non-Inferiority
Trial. Lancet Oncology, 10, 135-146. http://dx.doi.org/10.1016/S1470-2045(08)70341-3
Gralow, J.R., Blermann,
J.S.,
Farooki, A.,
Fornier, M.N.,
Gagel, R.F., Kumar, R., et al. (2013) NCCN Task Force Report: Bone Health in Cancer
Care. Journal of the National Comprehensive
Cancer Network: JNCCN, 11,
S1-S50.
Barakat, R.R., Bundy, B.N., Spirtos, N.M., Bell, J. and Mannel, R.S. (2006) Randomized Double-Blind Trial of Estrogen
Replacement Therapy
versus Placebo in Stage I or II Endometrial Cancer: A Gynecologic Oncology
Group Study. Journal of Clinical Oncology, 24, 587-592. http://dx.doi.org/10.1200/JCO.2005.02.8464
de Villiers, T.J., Pines, A., Panay, N., Gambacciani, M., Archer, D.F., Baber, R.J., et al., on Behalf
of the International Menopause Society (2013) Updated 2013 International Menopause Society
Recommendations on Menopausal Hormone Therapy and Preventive Strategies for Midlife Health. Climacteric, 16, 316-337. http://dx.doi.org/10.3109/13697137.2013.795683
Donders, G.,
Neven, P.,
Moegele, M.,
Lintermans, A.,
Bellen, G., Prasauskas, V., et al. (2014) Ultra-Low-Dose Estriol and Lactobacillus acidophilus Vaginal Tablets (Gynoflor)
for Vaginal Atrophy in Postmenopausal Breast Cancer Patients on Aromatase
Inhibitors: Pharmacokinetic, Safety, and Efficacy Phase I Clinical Study. Breast Cancer Research and Treatment, 145, 371-379. http://dx.doi.org/10.1007/s10549-014-2930-x
